Novel approaches to estimate prefrontal synaptic strength in vivo in humans: of relevance to depression, schizophrenia, and ketamine

Neuropsychopharmacology. 2022 Jan;47(1):399-400. doi: 10.1038/s41386-021-01122-2.

Chadi G Abdallah^{1

2

3

4

5}, Graeme F Mason^{6

7}

¹ Michael E. DeBakey VA Medical Center, Houston, TX, USA. chadi.abdallah@bcm.edu.
² Menninger Department of Psychiatry, Baylor College of Medicine, Houston, TX, USA. chadi.abdallah@bcm.edu.
³ National Center for PTSD - Clinical Neurosciences Division, US Department of Veterans Affairs, West Haven, CT, USA. chadi.abdallah@bcm.edu.
⁴ Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. chadi.abdallah@bcm.edu.
⁵ Core for Advanced Magnetic Resonance Imaging (CAMRI), Baylor College of Medicine, Houston, TX, USA. chadi.abdallah@bcm.edu.
⁶ Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
⁷ Departments of Radiology & Biomedical Imaging and Biomedical Engineering, Yale University, New Haven, CT, USA.

No abstract available

Publication types